Cefprozil monohydrate

CAS: 121123-17-9

Ref. 3D-FC45309

Product Information

• Name: Cefprozil monohydrate
• Synonyms: Cefzil, Cefprozil Hydrate, Cefprozil Monohydrate, (6R-(6Alpha,7Beta(R*)))-7-((Amino(4-Hydroxyphenyl)Acetyl)Amino)-8-Oxo-3-(1-Propenyl)-5-Thia-1-Azabicyclo(4.2.0)Oct-2-Ene-2-Carboxylic Acid, 8-[2-Amino-2-(4-Hydroxyphenyl)-Acetyl]Amino-7-Oxo-4-Prop-1-Enyl-2-Thia-6-Azabicyclo[4.2.0]Oct-4-Ene-5-Carboxylic Acid, (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate, Bmy-28100-03-800, (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1Z)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1E)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate, (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1Z)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate, 7-{[amino(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1Z)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Description

Cefprozil is a cephalosporin antibiotic that binds to the penicillin-binding proteins in the bacterial cell wall, preventing the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis. It has been used as a treatment for streptococcal pharyngitis, bacterial rhinosinusitis, and other infections caused by gram-positive bacteria. Cefprozil has also been shown to have antiinflammatory properties. The mechanism of action for this drug is not well understood, but it has been shown to inhibit IL-2 receptor expression and IL-2 mediated activation of T cells in vitro. Cefprozil also inhibits induction of proinflammatory cytokines such as TNF-α and IL-1β by lipopolysaccharide (LPS) in vitro.

• Brand: Biosynth

Chemical properties

• Molecular weight: 407.44 g/mol
• Formula: C₁₈H₁₉N₃O₅S·H₂O
• Purity: Min. 95%